Sign In
Buy GMED
$86.15
+3.80 (+4.61%)
At Close: Aug 10, 2026
Globus Medical (GMED) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
10:15am, Wednesday, 05'th Nov 2025
Beyond analysts' top-and-bottom-line estimates for Globus Medical (GMED), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the q
Globus Medical (GMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
11:07am, Thursday, 30'th Oct 2025
Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globus Medical (GMED) to Release Earnings on Thursday
02:42am, Thursday, 30'th Oct 2025
Globus Medical (NYSE: GMED - Get Free Report) is anticipated to post its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect Globus Medical to post earnings of $0.79 per
Globus Medical (GMED) is a Top-Ranked Value Stock: Should You Buy?
10:41am, Wednesday, 29'th Oct 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Is Wall Street Underestimating Globus Medical Stock's Potential?
11:25am, Wednesday, 22'nd Oct 2025
Here's why we believe Globus Medical (GMED) stock merits attention as a value stock. It's currently trading approximately 33% below its 1-year high and is also trading at a PS multiple that falls belo
Globus Medical Schedules Third Quarter Earnings Release and Conference Call
04:30pm, Thursday, 16'th Oct 2025
AUDUBON, Pa., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal technology company, will announce its financial results for the third quarter ended Septembe
Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma
04:40pm, Tuesday, 14'th Oct 2025
AUDUBON, Pa., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, has announced the launch of the ANTHEM™ Elbow Fracture System, a full
GMED vs. SONVY: Which Stock Is the Better Value Option?
12:41pm, Tuesday, 14'th Oct 2025
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Globus Medical (GMED) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investo
Here's Why Globus Medical (GMED) is a Strong Value Stock
10:41am, Monday, 29'th Sep 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Globus Medical (GMED) is a Top Value Stock for the Long-Term
10:41am, Friday, 12'th Sep 2025
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Hold Onto Globus Medical Stock in Your Portfolio for Now?
01:31pm, Thursday, 04'th Sep 2025
GMED rides strong musculoskeletal demand and new launches, but faces currency headwinds and fierce competition.
Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.
04:30pm, Thursday, 28'th Aug 2025
AUDUBON, Pa., Aug. 28, 2025 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal technology company, announced that a Delaware jury has returned a verdict in favor of Globu
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand
09:26am, Wednesday, 13'th Aug 2025
GMED posts strong Q2 with earnings and revenues, boosted by the Nevro acquisition and expanded margins.
Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript
03:05pm, Friday, 08'th Aug 2025
Globus Medical, Inc. (NYSE:GMED ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Brian J. Kearns - Senior Vice President of Business Development & Investor Relations D
Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
08:01pm, Thursday, 07'th Aug 2025
Although the revenue and EPS for Globus Medical (GMED) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall S
